Matthias TREU,Stephan Karl ZAHN,Patricia AMOUZEGH,Cristina LECCI,Heather TYE
申请号：
US13329615
公开号：
US20120329771A1
申请日:
2011.12.19
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention encompasses compounds of general formula (I)wherein the groups R5 to R10, A, L1, B, m and p are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
